Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GABAPENTIN Cause Product use in unapproved indication? 4,919 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 4,919 reports of Product use in unapproved indication have been filed in association with GABAPENTIN (Gabapentin). This represents 6.6% of all adverse event reports for GABAPENTIN.

4,919
Reports of Product use in unapproved indication with GABAPENTIN
6.6%
of all GABAPENTIN reports
206
Deaths
965
Hospitalizations

How Dangerous Is Product use in unapproved indication From GABAPENTIN?

Of the 4,919 reports, 206 (4.2%) resulted in death, 965 (19.6%) required hospitalization, and 210 (4.3%) were considered life-threatening.

Is Product use in unapproved indication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GABAPENTIN. However, 4,919 reports have been filed with the FAERS database.

What Other Side Effects Does GABAPENTIN Cause?

Drug ineffective (10,914) Drug hypersensitivity (6,833) Off label use (6,729) Drug ineffective for unapproved indication (5,231) Toxicity to various agents (4,839) Completed suicide (4,111) Dizziness (4,107) Somnolence (3,798) Fatigue (3,791) Pain (3,656)

What Other Drugs Cause Product use in unapproved indication?

DUPILUMAB (33,452) DICLOFENAC (12,197) METHOTREXATE (8,930) PREDNISONE (7,625) RITUXIMAB (7,519) MYCOPHENOLATE MOFETIL (5,910) ACETAMINOPHEN (5,819) CYCLOPHOSPHAMIDE (5,750) RISPERIDONE (5,551) TACROLIMUS (5,057)

Which GABAPENTIN Alternatives Have Lower Product use in unapproved indication Risk?

GABAPENTIN vs GABAPENTIN ENACARBIL GABAPENTIN vs GADAVIST GABAPENTIN vs GADOBENATE DIMEGLUMINE GABAPENTIN vs GADOBUTROL GABAPENTIN vs GADODIAMIDE

Related Pages

GABAPENTIN Full Profile All Product use in unapproved indication Reports All Drugs Causing Product use in unapproved indication GABAPENTIN Demographics